Clinical Trial Update: A Proof of Concept Study of the Efficacy and Safety of Oral LAT8881 in Acute Migraine [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the efficacy and safety of oral LAT8881 in acute migraine has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• LAT8881

Snippet

Sponsor: Lateral Pharma Pty Ltd | Conditions: Acute Migraine | Phase 2 | Status: COMPLETED | Results posted: 2021-03-30